教育訓練：「AI藥物發展」

課程日期： 115年06月05日(五) 課程時間： 14:00-16:00 課程地點：線上課程課程講師：顧德諮詢有限公司/顧曼芹總經理

◇ COURSE SYLLABUS

◇ INSTRUCTOR﹍ DR. MANNCHING SHERRY KU

◇ POSITION﹍ GM OF KUDER CONSULTING INC.

◇ EDUCATION

9/78-9/83 Ph.D. in Pharmaceutics & Pharmaceutical Chemistry, The Ohio State University - GPA 3.88. Ph.D. Thesis on ADME including metabolite synthesis and C14 tissue distribution of Anticancer NCI contact Nucleosides under Professor Lou Malspeis.
in Pharmacy, B.S.9/74-6/78 National Taiwan University

◇ EXPERIENCE

Chairman of Board and Chief Executive Officer (CEO), Savior Lifetec Corp.
Founding President and Board member of Ruenhuei Biopharmaceuticals, Inc.
Founding President/CSO/Board member, TWi Biotech and TWi Pharma Inc.
Pfizer Co, Pearl River, NY 10965 (previously Wyeth Research/American Cyanamid/Lederle)
Vice Chairman, New Jersey Pharmaceutical Discussion Group
Member of the Executive Yuan Biotechnology Industry Strategy Advisory Committee (BTC)
In the 29-year tenure, she was promoted through the achievements: Developed more than 170 new clinical drugs, IND clinical research applications for 85 innovative new compounds and drugs, Successfully developed 9 marketed drugs, ect..

最新消息 / 最新消息